Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension-Reference-Cited by-同舟云学术

Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension

Published:2014-08-05 Issue:6 Volume:130 Page:496-507
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bubb Kristen J.¹,Trinder Sarah L.¹,Baliga Reshma S.¹,Patel Jigisha¹,Clapp Lucie H.¹,MacAllister Raymond J.¹,Hobbs Adrian J.¹

Affiliation:

1. From the William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London (K.J.B., S.L.T., R.S.B., A.J.H.); and Centre for Clinical Pharmacology, University College London (J.P., L.H.C., R.J.M.), London, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Pulmonary Arterial Hypertension

2. Pulmonary Arterial Hypertension

3. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

4. Bosentan Therapy for Pulmonary Arterial Hypertension

5. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice;GeroScience;2024-07-09

2. Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension;Acta Pharmaceutica Sinica B;2024-04

3. The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodelling via redox and inflammatory mechanisms.;American Journal of Physiology-Heart and Circulatory Physiology;2023-12-22

4. Capillary leak and endothelial permeability in critically ill patients: a current overview;Intensive Care Medicine Experimental;2023-12-20

5. The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension;Metabolites;2023-11-16